by Raleigh Malik | Mar 15, 2013
Guest commentator and president of the Greater Indianapolis Chamber of Commerce, Scott Miller cited the news of Pearl’s expansion as a sign of the growing life science industry in Indiana in a recent article on nwi.com. Miller’s article describes the current state of...
by Raleigh Malik | Mar 15, 2013
The Indiana Medical Device Manufacturer’s Council (IMDMC) is hosting an event featuring a panel of experts on the legal implications of the new Sunshine Law. Topic: Sunshine Law Final Rule: How to Ensure Compliance When: March 27, 2013 Where: Montage...
by Raleigh Malik | Mar 13, 2013
Therapeutic proteins can sometimes elicit a harmful immune response, compromising patient health and product efficacy. In response to this, FDA recently issued draft guidance entitled, “Immunogenicity Assessment for Therapeutic Proteins,” aimed to assist manufactures...
by Raleigh Malik | Mar 13, 2013
Check out the Center for Disease Control & Prevention’s fascinating infographic depicting the percent decrease of various common infectious diseases, since the discovery of vaccines in the US. Every once in a while we get a glimpse at some data that keeps...
by Raleigh Malik | Feb 28, 2013
The FDA adopted a Q&A from the International Conference on Harmonisation (IHC) to clarify the industry guidance, “E3 Structure and Content of Clinical Study Reports” (IHC E3), according to a recent article on outsourching-pharma.com. The purpose of the...
